Investing.com – J&J (NYSE: ) reported second quarter EPS of $2.82, $0.10 better than the analyst estimate of $2.72. Revenue for the quarter came in at $22.45B versus the consensus estimate of $22.34B.
Guidance
J&J sees FY 2024 EPS of $10.05 versus the analyst consensus of $10.01.
J&J’s stock price closed at $151.01. It is up 2.10% in the last 3 months and down -5.06% in the last 12 months.
J&J saw 3 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See J&J’s stock price’s past reactions to earnings here.
According to InvestingPro, J&J’s Financial Health score is “great performance”.
Check out J&J’s , and J&J’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
